Workflow
Ultragenyx Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
RAREUltragenyx Pharmaceutical(RARE) GlobeNewswire News Room·2024-06-13 04:05

A registration statement relating to these securities has been filed with the Securities and Exchange Commission and became automatically effective on February 21, 2024. This offering is being made solely by means of a prospectus supplement and accompanying prospectus. When available, copies of the preliminary prospectus supplement and the accompanying prospectus related to the offering may be obtained from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, Ne ...